Massimo Mantegazza - Publications

Affiliations: 
CNRS & University of Nice (France) 
Area:
Sodium Channels, Neuronal Excitability, Epilepsy, Migraine
Website:
http://www.ipmc.cnrs.fr/?page=mantegazza&lang=uk

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Rusina E, Simonti M, Duprat F, Cestèle S, Mantegazza M. Voltage-gated sodium channels in genetic epilepsy: up and down of excitability. Journal of Neurochemistry. PMID 37654020 DOI: 10.1111/jnc.15947  0.411
2023 Lemaire L, Desroches M, Krupa M, Mantegazza M. Idealized multiple-timescale model of cortical spreading depolarization initiation and pre-epileptic hyperexcitability caused by Na1.1/SCN1A mutations. Journal of Mathematical Biology. 86: 92. PMID 37171678 DOI: 10.1007/s00285-023-01917-5  0.415
2023 Scalmani P, Paterra R, Mantegazza M, Avoli M, de Curtis M. Involvement of GABAergic interneuron subtypes in 4-aminopyridine-induced seizure-like events in mouse entorhinal cortex . The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 36810229 DOI: 10.1523/JNEUROSCI.1190-22.2023  0.304
2022 Guerrini R, Conti V, Mantegazza M, Balestrini S, Galanopoulou AS, Benfenati F. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum. Physiological Reviews. PMID 35951482 DOI: 10.1152/physrev.00063.2021  0.308
2022 Beretta S, Gritti L, Ponzoni L, Scalmani P, Mantegazza M, Sala M, Verpelli C, Sala C. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K). Molecular Autism. 13: 1. PMID 34980259 DOI: 10.1186/s13229-021-00484-0  0.352
2021 Chever O, Zerimech S, Scalmani P, Lemaire L, Pizzamiglio L, Loucif A, Ayrault M, Krupa M, Desroches M, Duprat F, Léna I, Cestèle S, Mantegazza M. Initiation of migraine-related cortical spreading depolarization by hyperactivity of GABAergic neurons and NaV1.1 channels. The Journal of Clinical Investigation. PMID 34491914 DOI: 10.1172/JCI142203  0.366
2021 Lemaire L, Desroches M, Krupa M, Pizzamiglio L, Scalmani P, Mantegazza M. Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine. Plos Computational Biology. 17: e1009239. PMID 34314446 DOI: 10.1371/journal.pcbi.1009239  0.449
2021 Mantegazza M, Cestèle S, Catterall W. Sodium Channelopathies of Skeletal Muscle and Brain. Physiological Reviews. PMID 33769100 DOI: 10.1152/physrev.00025.2020  0.525
2020 Culotta L, Scalmani P, Vinci E, Terragni B, Sessa A, Broccoli V, Mantegazza M, Boeckers T, Verpelli C. SULT4A1 Modulates Synaptic Development and Function by Promoting the Formation of PSD-95/NMDAR Complex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 40: 7013-7026. PMID 32801157 DOI: 10.1523/Jneurosci.2194-19.2020  0.358
2020 Zerimech S, Chever O, Scalmani P, Pizzamiglio L, Duprat F, Mantegazza M. Cholinergic modulation inhibits cortical spreading depression in mouse neocortex through activation of muscarinic receptors and decreased excitatory/inhibitory drive. Neuropharmacology. 166: 107951. PMID 31945385 DOI: 10.1016/J.Neuropharm.2020.107951  0.323
2019 Mantegazza M, Broccoli V. SCN1A/Na 1.1 channelopathies: Mechanisms in expression systems, animal models, and human iPSC models. Epilepsia. 60: S25-S38. PMID 31904127 DOI: 10.1111/Epi.14700  0.474
2019 Desroches M, Faugeras O, Krupa M, Mantegazza M. Modeling cortical spreading depression induced by the hyperactivity of interneurons. Journal of Computational Neuroscience. PMID 31620945 DOI: 10.1007/S10827-019-00730-8  0.418
2019 Léna I, Mantegazza M. Na1.2 haploinsufficiency in Scn2a knock-out mice causes an autistic-like phenotype attenuated with age. Scientific Reports. 9: 12886. PMID 31501495 DOI: 10.1038/S41598-019-49392-7  0.415
2019 Marcuzzo S, Terragni B, Bonanno S, Isaia D, Cavalcante P, Cappelletti C, Ciusani E, Rizzo A, Regalia G, Yoshimura N, Ugolini GS, Rasponi M, Bechi G, Mantegazza M, Mantegazza R, et al. Hyperexcitability in Cultured Cortical Neuron Networks from the G93A-SOD1 Amyotrophic Lateral Sclerosis Model Mouse and its Molecular Correlates. Neuroscience. PMID 31400485 DOI: 10.1016/J.Neuroscience.2019.07.041  0.337
2019 Corti A, Sota R, Dugo M, Calogero RA, Terragni B, Mantegazza M, Franceschetti S, Restelli M, Gasparini P, Lecis D, Chrzanowska KH, Delia D. DNA damage and transcriptional regulation in iPSC-derived neurons from Ataxia Telangiectasia patients. Scientific Reports. 9: 651. PMID 30679601 DOI: 10.1038/S41598-018-36912-0  0.354
2019 Salgueiro-Pereira AR, Duprat F, Pousinha P, Loucif A, Douchamps V, Regondi C, Ayrault M, Eugie M, Stunault MI, Escayg A, Goutagny R, Gnatkovsky V, Frassoni C, Marie H, Bethus I, ... Mantegazza M, et al. A two-hit story: Seizures and genetic mutation interaction sets phenotype severity in SCN1A epilepsies. Neurobiology of Disease. PMID 30659983 DOI: 10.1016/J.Nbd.2019.01.006  0.473
2019 Contesse T, Ayrault M, Mantegazza M, Studer M, Deschaux O. Hyperactive and anxiolytic-like behaviors result from loss of COUP-TFI/Nr2f1 in the mouse cortex. Genes, Brain, and Behavior. e12556. PMID 30653836 DOI: 10.1111/Gbb.12556  0.3
2018 Castagnola S, Delhaye S, Folci A, Paquet A, Brau F, Duprat F, Jarjat M, Grossi M, Béal M, Martin S, Mantegazza M, Bardoni B, Maurin T. New Insights Into the Role of Ca2 Protein Family in Calcium Flux Deregulation in -KO Neurons. Frontiers in Molecular Neuroscience. 11: 342. PMID 30319351 DOI: 10.3389/Fnmol.2018.00342  0.338
2018 Dhifallah S, Lancaster E, Merrill S, Leroudier N, Mantegazza M, Cestèle S. Gain of Function for the /hNa1.1-L1670W Mutation Responsible for Familial Hemiplegic Migraine. Frontiers in Molecular Neuroscience. 11: 232. PMID 30038559 DOI: 10.3389/Fnmol.2018.00232  0.456
2018 May P, Girard S, Harrer M, Bobbili DR, Schubert J, Wolking S, Becker F, Lachance-Touchette P, Meloche C, Gravel M, Niturad CE, Knaus J, De Kovel C, Toliat M, Polvi A, ... ... Mantegazza M, et al. Rare coding variants in genes encoding GABA receptors in genetic generalised epilepsies: an exome-based case-control study. The Lancet. Neurology. 17: 699-708. PMID 30033060 DOI: 10.1016/S1474-4422(18)30215-1  0.331
2018 Alari V, Russo S, Terragni B, Ajmone PF, Sironi A, Catusi I, Calzari L, Concolino D, Marotta R, Milani D, Giardino D, Mantegazza M, Gervasini C, Finelli P, Larizza L. iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability. Stem Cell Research. 30: 130-140. PMID 29883886 DOI: 10.1016/J.Scr.2018.05.019  0.383
2017 Mantegazza M, Cestèle S. Pathophysiological mechanisms of migraine and epilepsy: similarities and differences. Neuroscience Letters. PMID 29129678 DOI: 10.1016/J.Neulet.2017.11.025  0.442
2017 Mantegazza M. Epilepsy: Advances in Genetics and Pathophysiology. Neuroscience Letters. PMID 29054433 DOI: 10.1016/J.Neulet.2017.10.026  0.334
2017 Binini N, Sancini G, Villa C, Magro RD, Sansoni V, Rusconi R, Mantegazza M, Grioni D, Talpo F, Toselli M, Combi R. Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE). Brain Research. 1677: 26-32. PMID 28951233 DOI: 10.1016/J.Brainres.2017.09.023  0.458
2017 Montani C, Ramos-Brossier M, Ponzoni L, Gritti L, Cwetsch AW, Braida D, Saillour Y, Terragni B, Mantegazza M, Sala M, Verpelli C, Billuart P, Sala C. The X-linked intellectual disability protein IL1RAPL1 regulates dendrite complexity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28576939 DOI: 10.1523/Jneurosci.3775-16.2017  0.386
2017 Terragni B, Scalmani P, Franceschetti S, Cestèle S, Mantegazza M. Post-translational dysfunctions in channelopathies of the nervous system. Neuropharmacology. PMID 28571716 DOI: 10.1016/J.Neuropharm.2017.05.028  0.404
2017 Avanzini G, Mantegazza M, Terragni B, Canafoglia L, Scalmani P, Franceschetti S. The impact of genetic and experimental studies on classification and therapy of the epilepsies. Neuroscience Letters. PMID 28522348 DOI: 10.1016/J.Neulet.2017.05.026  0.42
2017 Kapetis D, Sassone J, Yang Y, Galbardi B, Xenakis MN, Westra RL, Szklarczyk R, Lindsey P, Faber CG, Gerrits M, Merkies IS, Dib-Hajj SD, Mantegazza M, Waxman SG, Lauria G, et al. Network topology of NaV1.7 mutations in sodium channel-related painful disorders. Bmc Systems Biology. 11: 28. PMID 28235406 DOI: 10.1186/S12918-016-0382-0  0.414
2016 Khalfallah O, Jarjat M, Davidovic L, Nottet N, Cestèle S, Mantegazza M, Bardoni B. Depletion of the fragile X mental retardation protein in embryonic stem cells alters the kinetics of neurogenesis. Stem Cells (Dayton, Ohio). PMID 27664080 DOI: 10.1002/Stem.2505  0.327
2016 Terragni B, Scalmani P, Colombo E, Franceschetti S, Mantegazza M. Ranolazine can block with less efficacy the persistent Na(+) current and more efficacy the transient Na(+) current than phenytoin in central neurons. Neuropharmacology. PMID 27450092 DOI: 10.1016/J.Neuropharm.2016.06.029  0.443
2016 Vicidomini C, Ponzoni L, Lim D, Schmeisser MJ, Reim D, Morello N, Orellana D, Tozzi A, Durante V, Scalmani P, Mantegazza M, Genazzani AA, Giustetto M, Sala M, Calabresi P, et al. Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice. Molecular Psychiatry. PMID 27021819 DOI: 10.1038/Mp.2016.30  0.338
2016 De Stasi AM, Farisello P, Marcon I, Cavallari S, Forli A, Vecchia D, Losi G, Mantegazza M, Panzeri S, Carmignoto G, Bacci A, Fellin T. Unaltered Network Activity and Interneuronal Firing During Spontaneous Cortical Dynamics In Vivo in a Mouse Model of Severe Myoclonic Epilepsy of Infancy. Cerebral Cortex (New York, N.Y. : 1991). PMID 26819275 DOI: 10.1093/Cercor/Bhw002  0.39
2015 Bechi G, Rusconi R, Cestèle S, Striano P, Franceschetti S, Mantegazza M. Rescuable folding defective NaV1.1 (SCN1A) mutants in epilepsy: properties, occurrence, and novel rescuing strategy with peptides targeted to the endoplasmic reticulum. Neurobiology of Disease. 75: 100-14. PMID 25576396 DOI: 10.1016/J.Nbd.2014.12.028  0.454
2015 Mantegazza M, Rusconi R, Cestèle S. Mutations of ion channels in genetic epilepsies Epilepsy Towards the Next Decade: New Trends and Hopes in Epileptology. 15-34. DOI: 10.1007/978-3-319-12283-0_2  0.375
2014 Hedrich UB, Liautard C, Kirschenbaum D, Pofahl M, Lavigne J, Liu Y, Theiss S, Slotta J, Escayg A, Dihné M, Beck H, Mantegazza M, Lerche H. Impaired action potential initiation in GABAergic interneurons causes hyperexcitable networks in an epileptic mouse model carrying a human Na(V)1.1 mutation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14874-89. PMID 25378155 DOI: 10.1523/Jneurosci.0721-14.2014  0.523
2014 Li T, Tian C, Scalmani P, Frassoni C, Mantegazza M, Wang Y, Yang M, Wu S, Shu Y. Action potential initiation in neocortical inhibitory interneurons. Plos Biology. 12: e1001944. PMID 25203314 DOI: 10.1371/Journal.Pbio.1001944  0.461
2014 Carlessi L, Fusar Poli E, Bechi G, Mantegazza M, Pascucci B, Narciso L, Dogliotti E, Sala C, Verpelli C, Lecis D, Delia D. Functional and molecular defects of hiPSC-derived neurons from patients with ATM deficiency. Cell Death & Disease. 5: e1342. PMID 25032865 DOI: 10.1038/Cddis.2014.310  0.355
2014 Guerrini R, Marini C, Mantegazza M. Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 269-85. PMID 24664660 DOI: 10.1007/S13311-014-0267-0  0.467
2013 Verpelli C, Carlessi L, Bechi G, Fusar Poli E, Orellana D, Heise C, Franceschetti S, Mantegazza R, Mantegazza M, Delia D, Sala C. Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells. Frontiers in Cellular Neuroscience. 7: 175. PMID 24109433 DOI: 10.3389/Fncel.2013.00175  0.336
2013 Cestèle S, Schiavon E, Rusconi R, Franceschetti S, Mantegazza M. Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects. Proceedings of the National Academy of Sciences of the United States of America. 110: 17546-51. PMID 24101488 DOI: 10.1073/Pnas.1309827110  0.448
2013 Partemi S, Cestèle S, Pezzella M, Campuzano O, Paravidino R, Pascali VL, Zara F, Tassinari CA, Striano S, Oliva A, Brugada R, Mantegazza M, Striano P. Loss-of-function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death. Epilepsia. 54: e112-6. PMID 23899126 DOI: 10.1111/Epi.12259  0.42
2013 Liautard C, Scalmani P, Carriero G, de Curtis M, Franceschetti S, Mantegazza M. Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome. Epilepsia. 54: 1251-61. PMID 23663038 DOI: 10.1111/Epi.12213  0.449
2013 Cestèle S, Labate A, Rusconi R, Tarantino P, Mumoli L, Franceschetti S, Annesi G, Mantegazza M, Gambardella A. Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine. Epilepsia. 54: 927-35. PMID 23398611 DOI: 10.1111/Epi.12123  0.368
2013 Colombo E, Franceschetti S, Avanzini G, Mantegazza M. Phenytoin inhibits the persistent sodium current in neocortical neurons by modifying its inactivation properties. Plos One. 8: e55329. PMID 23383157 DOI: 10.1371/Journal.Pone.0055329  0.471
2012 Goaillard JM, Groc L, Lévi S, Mantegazza M, Matifat F, Morel JL, Baron-Forster A. The 22nd ion channel meeting, september 2011, france. Channels (Austin, Tex.). 6: 149-53. PMID 22647366 DOI: 10.4161/Chan.20795  0.346
2012 Bechi G, Scalmani P, Schiavon E, Rusconi R, Franceschetti S, Mantegazza M. Pure haploinsufficiency for Dravet syndrome Na(V)1.1 (SCN1A) sodium channel truncating mutations. Epilepsia. 53: 87-100. PMID 22150645 DOI: 10.1111/J.1528-1167.2011.03346.X  0.474
2011 Mantegazza M. Dravet syndrome: insights from in vitro experimental models. Epilepsia. 52: 62-9. PMID 21463283 DOI: 10.1111/J.1528-1167.2011.03005.X  0.456
2010 Marini C, Mantegazza M. Na+ channelopathies and epilepsy: recent advances and new perspectives. Expert Review of Clinical Pharmacology. 3: 371-84. PMID 22111617 DOI: 10.1586/Ecp.10.20  0.517
2010 Mantegazza M, Rusconi R, Scalmani P, Avanzini G, Franceschetti S. Epileptogenic ion channel mutations: from bedside to bench and, hopefully, back again. Epilepsy Research. 92: 1-29. PMID 20828990 DOI: 10.1016/J.Eplepsyres.2010.08.003  0.443
2010 Mantegazza M, Curia G, Biagini G, Ragsdale DS, Avoli M. Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. The Lancet. Neurology. 9: 413-24. PMID 20298965 DOI: 10.1016/S1474-4422(10)70059-4  0.678
2010 Mantegazza M, Catterall WA. Voltage-gated Na+ channels and epilepsy Epilepsia. 51: 9. DOI: 10.1111/J.1528-1167.2010.02795.X  0.628
2009 Riva D, Vago C, Pantaleoni C, Bulgheroni S, Mantegazza M, Franceschetti S. Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes. American Journal of Medical Genetics. Part A. 149: 2339-45. PMID 19764027 DOI: 10.1002/Ajmg.A.33029  0.389
2009 Tang B, Dutt K, Papale L, Rusconi R, Shankar A, Hunter J, Tufik S, Yu FH, Catterall WA, Mantegazza M, Goldin AL, Escayg A. A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation. Neurobiology of Disease. 35: 91-102. PMID 19409490 DOI: 10.1016/J.Nbd.2009.04.007  0.627
2009 Rusconi R, Combi R, Cestèle S, Grioni D, Franceschetti S, Dalprà L, Mantegazza M. A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS+: common mechanism in Nav1.1 related epilepsies? Human Mutation. 30: E747-60. PMID 19402159 DOI: 10.1002/Humu.21041  0.478
2008 Cestèle S, Scalmani P, Rusconi R, Terragni B, Franceschetti S, Mantegazza M. Self-limited hyperexcitability: functional effect of a familial hemiplegic migraine mutation of the Nav1.1 (SCN1A) Na+ channel. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7273-83. PMID 18632931 DOI: 10.1523/Jneurosci.4453-07.2008  0.528
2007 Rusconi R, Scalmani P, Cassulini RR, Giunti G, Gambardella A, Franceschetti S, Annesi G, Wanke E, Mantegazza M. Modulatory proteins can rescue a trafficking defective epileptogenic Nav1.1 Na+ channel mutant. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 11037-46. PMID 17928445 DOI: 10.1523/Jneurosci.3515-07.2007  0.5
2007 Avanzini G, Franceschetti S, Mantegazza M. Epileptogenic channelopathies: experimental models of human pathologies. Epilepsia. 48: 51-64. PMID 17571353 DOI: 10.1111/J.1528-1167.2007.01067.X  0.496
2007 Curia G, Aracri P, Colombo E, Scalmani P, Mantegazza M, Avanzini G, Franceschetti S. Phosphorylation of sodium channels mediated by protein kinase-C modulates inhibition by topiramate of tetrodotoxin-sensitive transient sodium current. British Journal of Pharmacology. 150: 792-7. PMID 17279091 DOI: 10.1038/Sj.Bjp.0707144  0.444
2007 Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, Spain WJ, McKnight GS, Scheuer T, Catterall WA. Erratum: Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy Nature Neuroscience. 10: 134-134. DOI: 10.1038/Nn0107-134B  0.541
2006 Scalmani P, Rusconi R, Armatura E, Zara F, Avanzini G, Franceschetti S, Mantegazza M. Effects in neocortical neurons of mutations of the Na(v)1.2 Na+ channel causing benign familial neonatal-infantile seizures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 10100-9. PMID 17021166 DOI: 10.1523/Jneurosci.2476-06.2006  0.534
2006 Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, Spain WJ, McKnight GS, Scheuer T, Catterall WA. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nature Neuroscience. 9: 1142-9. PMID 16921370 DOI: 10.1038/Nn1754  0.646
2006 Aracri P, Colombo E, Mantegazza M, Scalmani P, Curia G, Avanzini G, Franceschetti S. Layer-specific properties of the persistent sodium current in sensorimotor cortex. Journal of Neurophysiology. 95: 3460-8. PMID 16467432 DOI: 10.1152/Jn.00588.2005  0.322
2006 Colosimo E, Gambardella A, Mantegazza M, Labate A, Rusconi R, Schiavon E, Annesi F, Cassulini RR, Carrideo S, Chifari R, Canevini MP, Canger R, Franceschetti S, Annesi G, Wanke E, et al. Electroclinical features of a family with SCN1A loss-of-function mutation associated with simple febrile seizures | Caratteristiche elettrocliniche di una famiglia con convulsioni febbrili semplici associata a mutazione con perdita della funzione di SCN1A Bollettino - Lega Italiana Contro L'Epilessia. 265-266.  0.307
2005 Mantegazza M, Gambardella A, Rusconi R, Schiavon E, Annesi F, Cassulini RR, Labate A, Carrideo S, Chifari R, Canevini MP, Canger R, Franceschetti S, Annesi G, Wanke E, Quattrone A. Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. Proceedings of the National Academy of Sciences of the United States of America. 102: 18177-82. PMID 16326807 DOI: 10.1073/Pnas.0506818102  0.479
2005 Mantegazza M, Cestèle S. Beta-scorpion toxin effects suggest electrostatic interactions in domain II of voltage-dependent sodium channels. The Journal of Physiology. 568: 13-30. PMID 16020455 DOI: 10.1113/Jphysiol.2005.093484  0.385
2005 Mantegazza M, Yu FH, Powell AJ, Clare JJ, Catterall WA, Scheuer T. Molecular determinants for modulation of persistent sodium current by G-protein betagamma subunits. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 3341-9. PMID 15800189 DOI: 10.1523/Jneurosci.0104-05.2005  0.571
2005 Srairi-Abid N, Guijarro JI, Benkhalifa R, Mantegazza M, Cheikh A, Ben Aissa M, Haumont PY, Delepierre M, El Ayeb M. A new type of scorpion Na+-channel-toxin-like polypeptide active on K+ channels. The Biochemical Journal. 388: 455-64. PMID 15656785 DOI: 10.1042/Bj20041407  0.395
2004 M'Barek S, Fajloun Z, Cestèle S, Devaux C, Mansuelle P, Mosbah A, Jouirou B, Mantegazza M, Van Rietschoten J, El Ayeb M, Rochat H, Sabatier JM, Sampieri F. First chemical synthesis of a scorpion alpha-toxin affecting sodium channels: the Aah I toxin of Androctonus australis hector. Journal of Peptide Science : An Official Publication of the European Peptide Society. 10: 666-77. PMID 15568681 DOI: 10.1002/Psc.582  0.32
2004 Curia G, Aracri P, Sancini G, Mantegazza M, Avanzini G, Franceschetti S. Protein-kinase C-dependent phosphorylation inhibits the effect of the antiepileptic drug topiramate on the persistent fraction of sodium currents. Neuroscience. 127: 63-8. PMID 15219669 DOI: 10.1016/J.Neuroscience.2004.04.040  0.439
2001 Mantegazza M, Yu FH, Catterall WA, Scheuer T. Role of the C-terminal domain in inactivation of brain and cardiac sodium channels. Proceedings of the National Academy of Sciences of the United States of America. 98: 15348-53. PMID 11742069 DOI: 10.1073/Pnas.211563298  0.533
2001 Cestèle S, Scheuer T, Mantegazza M, Rochat H, Catterall WA. Neutralization of gating charges in domain II of the sodium channel alpha subunit enhances voltage-sensor trapping by a beta-scorpion toxin. The Journal of General Physiology. 118: 291-302. PMID 11524459 DOI: 10.1085/Jgp.118.3.291  0.551
1999 Taverna S, Sancini G, Mantegazza M, Franceschetti S, Avanzini G. Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. The Journal of Pharmacology and Experimental Therapeutics. 288: 960-8. PMID 10027832  0.338
1998 Taverna S, Mantegazza M, Franceschetti S, Avanzini G. Valproate selectively reduces the persistent fraction of Na+ current in neocortical neurons. Epilepsy Research. 32: 304-8. PMID 9761329 DOI: 10.1016/S0920-1211(98)00060-6  0.411
1998 Mantegazza M, Franceschetti S, Avanzini G. Anemone toxin (ATX II)-induced increase in persistent sodium current: effects on the firing properties of rat neocortical pyramidal neurones. The Journal of Physiology. 507: 105-16. PMID 9490824 DOI: 10.1111/J.1469-7793.1998.105Bu.X  0.385
Show low-probability matches.